Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats. - Wikidata - awgldk - TriplyDB

Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats.

Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats.

http://www.wikidata.org/entity/Q37286814

about

Reduced blood glucose through thyroid hormone degradation product.Beneficial effects of thyroid hormone on adipose inflammation and insulin sensitivity of obese Wistar rats.

P2860

Q48112061-F08C3303-E0E2-4657-9344-890AEF00E845 Q49502882-1803897B-9E39-40EC-9391-EE502B909969

P2860

Thyroid hormone treatment decreases hepatic glucose production and renal reabsorption of glucose in alloxan-induced diabetic Wistar rats.

http://www.wikidata.org/entity/Q37286814

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Thyroid hormone treatment decr ...... -induced diabetic Wistar rats.

@en

Thyroid hormone treatment decr ...... -induced diabetic Wistar rats.

@nl

type

label

Thyroid hormone treatment decr ...... -induced diabetic Wistar rats.

@en

Thyroid hormone treatment decr ...... -induced diabetic Wistar rats.

@nl

prefLabel

Thyroid hormone treatment decr ...... -induced diabetic Wistar rats.

@en

Thyroid hormone treatment decr ...... -induced diabetic Wistar rats.

@nl

P1433

Q37286814-3E345A71-D6EB-4E98-B9C6-D6D0F1ECA12E

P1476

Q37286814-9C156299-C6DC-4DDE-B4D6-D151D916C4ED

P2093

Q37286814-05303CAF-031A-4EC2-83B3-4B17DB167CBC

Q37286814-2A9364AE-73D4-4167-B62B-E749C8F65479

Q37286814-305F61CD-12A2-40C5-9166-B753B80F0766

Q37286814-6FD60D8B-1FBF-46CE-A97E-7260669E5BCE

Q37286814-71298C16-66E6-4A14-86D3-73CE36985018

Q37286814-CBDC4998-1686-45D7-AC8F-AAC1E4373A7C

Q37286814-D69258F2-FAFA-42E2-8330-8064B1EA5A4E

Q37286814-E6E8AD5C-C40A-44E2-89A0-6A2F6E574AD2

P2860

Q37286814-0168B0DE-ECE9-40BE-B1BF-FDD84E78E175

Q37286814-0ACEB42C-F49B-4373-B490-FAD4F4CEDCF5

Q37286814-11064E7C-E98C-4C82-9CC5-ADBCDB4576AC

Q37286814-139741D5-A132-410D-B67F-C99610B46369

Q37286814-184B7513-557A-46B5-893F-613BA1800BE6

Q37286814-2D2ED8D2-A8D7-4B82-858D-893F460D5085

Q37286814-3D3FEBFC-AF41-4B3C-83D4-0650EE4BDC90

Q37286814-3F6315FD-F6A3-418E-8F56-EC0F5CA1D061

Q37286814-57B51F08-DA91-4A46-A04E-D4F83A6ABC80

Q37286814-5E7A9B62-AC85-44CF-A2B6-297EE24379E0

P31

Q37286814-29087D77-2FFE-44F5-BC4E-3D6F0AE01AF7

P356

Q37286814-1CB6AEF7-CB4C-432C-9F1B-9063DADA9B5D

P433

Q37286814-42510ABE-FBB3-454E-8E3F-12B90FD6A0B1

P478

Q37286814-B73C68B2-395C-4AEB-B9B6-19637878DDAD

P577

Q37286814-1AEC279C-228D-41B2-887F-0731DBB7367F

P698

Q37286814-39473283-674E-45EF-A7CA-C6B50D791255

P921

Q37286814-1fe25829-66e0-47fb-9ad1-8904f9f53a5d

Q37286814-2580CC8D-E86A-4B3B-AFE5-A0078C6DCE50

P932

Q37286814-AF2B1365-B428-4114-9C21-DEC3B4A59058

P356

P1433

Physiological Reports

P1476

Thyroid hormone treatment decr ...... -induced diabetic Wistar rats.

@en

P2093

Aline Carvalho

http://www.w3.org/2001/XMLSchema#string

Ana C Panveloski-Costa

http://www.w3.org/2001/XMLSchema#string

Any de Castro Ruiz Marque

http://www.w3.org/2001/XMLSchema#string

Fabiana P Monteiro Schiavon

http://www.w3.org/2001/XMLSchema#string

Maria T Nunes

http://www.w3.org/2001/XMLSchema#string

Raquel S Campello

http://www.w3.org/2001/XMLSchema#string

Roberto B Bazotte

http://www.w3.org/2001/XMLSchema#string

Silvania da Silva Teixeira

http://www.w3.org/2001/XMLSchema#string

P2860

Endotoxin induced hyperlactatemia and hypoglycemia is linked to decreased mitochondrial phosphoenolpyruvate carboxykinase

Monochloroacetic acid inhibits liver gluconeogenesis by inactivating glyceraldehyde-3-phosphate dehydrogenase

New insights into the role and mechanism of glycogen synthase activation by insulin.

Action of thyroid hormones at the cellular level: the mitochondrial target.

SGLT2 inhibition--a novel strategy for diabetes treatment.

Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.

Thyroid hormone excess and glucose intolerance.

Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models.

Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes

FoxO proteins in insulin action and metabolism.

P31

scholarly article

P356

10.14814/PHY2.12961

http://www.w3.org/2001/XMLSchema#string

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27655796

http://www.w3.org/2001/XMLSchema#string

P921

P932

5037915

http://www.w3.org/2001/XMLSchema#string